• Izzaddinn Ahmed Department of Internal Medicine, Faculty of Medicine, University of Tabuk, Tabuk 71491 P.O. Box 741, Kingdom of Saudi Arabia.
  • Yassin Ibrahim Department of Family & Community Medicine, Faculty of Medicine, University of Tabuk, Tabuk, 71491 P.O Box 741, Kingdom of Saudi Arabia. https://orcid.org/0000-0003-1867-0312


Ramadan, Fasting, Smokeless tobacco, Withdrawal


In Ramadan, Muslims fast. Smokeless tobacco (SLT) users may experience withdrawal symptoms. The researchers aimed at assessing the frequency and severity of SLT withdrawal symptoms among Ramadan fasting SLT users. Using a pre and post observation: before and after Ramadan breakfast study was designed, a self-administered questionnaire was also created to validate and utilize the gathered data from the participants. The questionnaire was distributed to participants both directly and through social media. During Ramadan, 48 Sudanese males working in Saudi Arabia were evaluated for the effects of stopping SLT. The majority of them had no chronic illnesses and were employed, with average age of around 40 years, and average smoking duration of 17.19 years, 27% of them use other tobacco products. Friends impact in 47.91% of cases was the initial use motivator. On studying the first-dip symptoms, we found, in addition to other symptoms, the mood has improved in 81.25%, and concentration in 41.67% of cases. Before dipping SLT, 54.17% of participants break their fasting by ingesting adequate food and liquids. In 66.7% of cases, craving was the most noticeable symptom. As Ramadan progressed, we noted a statistically significant difference over time in the severity of the symptoms (P value 0.027). The SOWS score showed a significant difference between day 1 and day seven (P value <0.001), with a moderate degree of symptoms (mean 17.19). In this study, interrupted fasting has increased the chance of withdrawing from SLT. Symptoms get better as the length of such fasting increases. Noticeable symptoms of the first use are the improvement in mood and concentration. Further research is required to utilize Ramadan fast for quitting smoking.


Sreeramareddy CT, Pradhan PM, Sin S. Prevalence, distribution, and social determinants of tobacco use in 30 sub-Saharan African countries. BMC Med. 2014; 12:243.

Agbor MA, Azodo CC, Tefouet TSM. Smokeless tobacco use, tooth loss and oral health issues among adults in Cameroon. Afr Health Sci. 2013; 13:785– 90.

Kabwama SN, Ndyanabangi S, Mutungi G, Wesonga R, Bahendeka SK, Guwatudde D. Tobacco use and associated factors among adults in Uganda: findings from a nationwide survey. Tob Induc Dis. 2016; 14:27.

Hazarika NC, Biswas D, Phukan RK, Hazarika D, Mahanta J. Prevalence and pattern of substance abuse at bandardewa, a border area of assam and arunachal pradesh. Indian J Psychiatry. 2000;42 (3):262-266.

GBD 2019 Chewing Tobacco Collaborators. Spatial, temporal, and demographic patterns in prevalence of chewing tobacco use in 204 countries and territories, 1990-2019: a systematic analysis from the Global Burden of Disease Study 2019. Lancet Public Health. 2021 Jul;6 (7).

Cheng YC, Rostron BL, Day HR, Stanton CA, Hull LC, Persoskie A, Travers MJ, Taylor K, Conway KP, Ambrose BK, Borek N. Patterns of Use of Smokeless Tobacco in US Adults, 2013-2014. Am J Public Health. 2017 Sep;107(9):1508-1514.

Kasza, K. A. et al. Tobacco-product use by adults and youths in the United States in 2013 and 2014. N. Engl. J. Med. 376, 342–353, 2017.

Dunbar MS, Shadel WG, Tucker JS, Edelen MO. Use of and reasons for using multiple other tobacco products in daily and nondaily smokers: Associations with cigarette consumption and nicotine dependence. Drug Alcohol Depend. 2016 Nov 1; 168:156-163.

Noh JW, Kim MH, Lee Y, Kwon YD, Kim KB, Lee HJ, Yoo KB. Association between smokeless tobacco use and cigarette smoking amount by age. BMC Public Health. 2022 Mar 15;22(1):505.

?çmeli ÖS, Türker H, Gündo?u? B, Çiftci M, Aka Aktürk Ü. Behaviours and opinions of adolescent students on smoking. Tuberk Toraks. 2016 Sep;64(3):217-222.

Malenka RC, Nestler EJ, Hyman SE (2009). "Chapter 15: Reinforcement and Addictive Disorders". In Sydor A, Brown RY (eds.). Molecular Neuropharmacology: A Foundation for Clinical Neuroscience (2nd ed.). New York: McGraw-Hill Medical. pp. 364–368.

Moore RA, Aubin HJ. Do placebo 1response rates from cessation trials inform on strength of addictions? Int J Environ Res Public Health. 2012;9(1):192-211.

World Health Organization. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Volume 89: Smokeless Tobacco and Some Tobacco-Specific N-Nitrosamines.PDF–3.18 MB, Lyon, France: World Health Organization, International Agency for Research on Cancer, 2007, accessed 2014 Oct 31.

Le Foll B, Piper ME, Fowler CD, Tonstad S, Bierut L, Lu L, Jha P, Hall WD. Tobacco and nicotine use. Nat Rev Dis Primers. 2022 Mar 24;8(1):19.

Villanueva, H. F., James, J. R. & Rosecrans, J. A. Evidence of pharmacological tolerance to nicotine. NIDA Res. Monogr. 95, 349–350 (1989).

Morissette A, Ouellet-Plamondon C, Jutras-Aswad D. Craving as a core symptom in substance use disorders: epidemiology, neurobiological substrates and clinical relevance. Sante Ment Que. 2014;39(2):21-37.

Keizer I, Gex-Fabry M, Croquette P, Humair J, Khan AN. Tobacco craving and withdrawal symptoms in psychiatric patients during a motivational enhancement intervention based on a 26-hour smoking abstinence period. Tobacco Prevention & Cessation. 2019;5 June, 2022.

Taylor G, McNeill A, Girling A, Farley A, Lindson-Hawley N, Aveyard P. Change in mental health after smoking cessation: systematic review and meta-analysis. BMJ. 2014;348: g151.

West, R. The multiple facets of cigarette addiction and what they mean for encouraging and helping smokers to stop. COPD 6, 277–283 (2009).

Sagiroglu S, Erdogan A, Doganer A, Okyay RA. Otorhinolaryngological symptoms among smokeless tobacco (Maras powder) users. North Clin Istanb. 2018 Aug 8;6(3):284-292.

American Psychiatric Association. Diagnostic and Statistical Manual of Mental disorders 5th edn (American Psychiatric Association, 2013.

Gossop M. The development of a Short Opiate Withdrawal Scale (SOWS). Addict Behav. 1990;15(5):487-90.

Ussher M, Beard E, Abikoye G, Hajek P, West R. Urge to smoke over 52 weeks of abstinence. Psychopharmacology (Berl). 2013 Mar;226 (1):83-9.

ADEP, Missouri Curriculum Guide for Alcohol and Drug Education Programs, 120769NCJRS.PDF.

Barakat MM, Al-Qudah RA, Alfayoumi I, Al-Obaidi HJ, Jirjees FJ, Basheti I. Electronic cigarettes' withdrawal severity symptoms among users during intermittent fasting: a cross-sectional study. Addict Sci Clin Pract. 2021 Feb 5;16(1):10.

Pirie, K. et al. The 21st century hazards of smoking and benefits of stopping: a prospective study of one million women in the UK. Lancet 381, 133–141, 2013.

National Center for Chronic Disease Prevention and Health Promotion (US) Office on Smoking and Health. Smoking cessation: a report of the Surgeon General (Department of Health and Human Services, 2020.




How to Cite

Ahmed, I., & Ibrahim, Y. (2024). RAMADAN FASTING: A STEP IN QUITTING SMOKELESS TOBACCO AND ALLEVIATING ITS WITHDRAWAL SYMPTOMS. Malaysian Journal of Public Health Medicine, 24(1), 165–171. Retrieved from https://mjphm.org/index.php/mjphm/article/view/2393